Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination.

Ikediobi, Ogechi; Eichenfield, Dawn Z; Barrio, Victoria R

Ikediobi, Ogechi; Eichenfield, Dawn Z; Barrio, Victoria R.

Afiliación

Ikediobi O; Department of Dermatology, University of California, San Diego, San Diego, California, USA.
Eichenfield DZ; Department of Dermatology, Rady Children's Hospital, San Diego, California, USA.
Barrio VR; Department of Dermatology, University of California, San Diego, San Diego, California, USA.

Pediatr Dermatol ; 39(5): 823-824, 2022 Sep.

Article en En | MEDLINE | ID: mdl-35522122

RESUMEN

A 12-year-old boy presented with a 2-week history of persistent pruritic edematous plaques one day after he received the first dose of the BNT162b2 COVID-19 mRNA vaccine. A skin biopsy showed urticarial dermatitis with tissue eosinophilia consistent with a diagnosis of vaccine-associated eosinophilic cellulitis, with polyethylene glycol as a potential trigger.

Asunto(s)

Vacunas contra la COVID-19; COVID-19; Eosinofilia; Vacuna BNT162; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Celulitis (Flemón)/diagnóstico; Celulitis (Flemón)/etiología; Niño; Eosinofilia/diagnóstico; Humanos; Masculino; Polietilenglicoles; Vacunación; Vacunas Sintéticas; Vacunas de ARNm

Palabras clave

COVID-19; hypersensitivity; messenger RNA; pediatrics; vaccination

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Eosinofilia / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Child / Humans / Male Idioma: En Revista: Pediatr Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google